Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES) - a feasibility open label randomised trial

Norman, Jane (Principal Investigator)
Lang, Christopher (Co-investigator)
Seiler, E (Co-investigator)

Status	Finished
Effective start/end date	1/04/14 → 31/03/16

Funding

UK central government bodies/local authorities, health and hospital authorities: £268,120.00

1 Article

Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
Reynolds, R. M., Denison, F. C., Juszczak, E., Bell, J. M. L., Penneycard, J., Strachan, M. W. J., Lindsay, R. S., Health, S. C. F., Love, C. D. B., Whyte, S., Mackenzie, F., Stenson, B. & Norman, J. E., 22 Sept 2017, In: BMC pregnancy and childbirth.
Research output: Contribution to journal › Article › peer-review

Open Access
File